Cover Image
Read Now

CADTH Canadian Drug Expert Committee recommendation: Fluocinolone acetonide (Iluvien -- Knight Therapeutics Inc.) indication : diabetic macular edema

Recommendation: The CADTH Canadian Drug Expert Committee (CDEC) recommends that the fluocinolone acetonide intravitreal implant should not be reimbursed for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a...

Full description

Bibliographic Details
Corporate Author: CADTH Canadian Drug Expert Committee
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health September 2019, 2019
Series:CADTH common drug review
Subjects:
Insurance, Health, Reimbursement
Canada
Macular Edema / Drug Therapy
Cost-benefit Analysis
Intravitreal Injections
Fluocinolone Acetonide / Therapeutic Use
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:Recommendation: The CADTH Canadian Drug Expert Committee (CDEC) recommends that the fluocinolone acetonide intravitreal implant should not be reimbursed for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure
Physical Description:1 PDF file (8 pages)

Similar Items